Somaxon, Kimber Resources: Midday Volume Plays
Several stocks trading near $5 were moving on above-average volume during Monday's session.
01:17PM 11/30/09
Doc Offers Top Hep C Drug Picks: BioBuzz
Vertex, InterMune, Pharmasset get positive reviews after recent Hep C meeting.
01:54PM 11/09/09
ZymoGenetics Shrinks 3Q Loss As Revenue Rises
ZymoGenetics reports smaller loss on greater Recothrom revenue and lower research spending
07:28PM 11/05/09
Idenix Down; Novartis Won't License Drug Candidate
Idenix Pharmaceuticals shares fall after Novartis opts out of hepatitis C drug program
12:46PM 10/30/09
ZymoGenetics Shares Fall On Oppenheimer Downgrade
ZymoGenetics shares fall as analyst downgrades, citing valuation and risky programs
10:52AM 10/26/09
Fireworks Look Over (The Daily Swing Trade $)
Following an erratic options-expiration week, Friday will likely yield a quiet session.
05:45PM 08/20/09
ZymoGenetics Shares Rise, New Medical Chief Named
ZymoGenetics shares rise as Eleanor Ramos is named chief medical officer
11:07AM 06/11/09
Small-Cap Biotechs Pop Before Conference
Small-cap cancer drugs get a lift before the American Society of Clinical Oncology's annual meeting.
09:11AM 05/28/09
Bristol-Myers Posts 3.5 Percent Q1 Profit Dip
Bristol-Myers profit falls, but sales rise despite recession on Plavix, Abilify increases
07:30AM 04/28/09
Fitz Bits: Cisco Running a Bit Too Hot (RealMoney.com $)
After a run-up, it's overbought. Consider selling it and rebuying on a pullback.
12:59PM 01/29/09
Earnings Beat From a Drug Holding (Action Alerts PLUS $)
The company is preparing well for upcoming patent issues.
09:30AM 01/27/09
Bristol-Myers to Buy Rights to Hep C Drug
Bristol-Myers has agreed to pay $85 million upfront to ZymoGenetics for rights to PEG-Interferon lambda and will pay another $20 million license fee to ZymoGenetics in 2009, the companies announced Monday.
04:21PM 01/12/09



Connect with TheStreet